You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2

Article info

Article menu

Download PDFPDF

Poster Presentation
Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
Free

Authors

Citation

Kaufman HL, Aung S, Morse M, et al
Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
Journal for ImmunoTherapy of Cancer 2014;2:P88. doi: 10.1186/2051-1426-2-S3-P88

Publication history

  • First published November 6, 2014.
Online issue publication 
March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2014